EUVIMEDEUVIMED entdecken
Open Access

In vivo T‐cell depletion and pharmacokinetic‐based busulfan conditioning regimen improve the outcomes in acute myeloid leukemia (AML) in complete remission undergoing to allogeneic stem cell transplantation

Roberto Bono, Cristina Rotolo, Giuseppe Sapienza, Corinne Spoto, Carmelo Costanza, Sergio Indelicato, Caterina Patti, Antonino Mulè, Valeria Calafiore, Giulia Arrigo, Alessandra Santoro, Laura Di Noto und 1 weitere

Cancer · 15.08.2026 · 132 (16)

DOI: 10.1002/cncr.70545 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer, online erschienen am 15.08.2026. Verfasst von Roberto Bono und 12 weiteren Autor:innen. Beteiligte Einrichtung: AOR Villa Sofia Cervello, Palermo, Italy. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pharmacokinetic‐based busulfan administration improves the therapeutic window and in vivo T‐cell depletion with antilymphocyte globulins reduces graft‐versus‐host disease incidence. In this study, both were used, showing an improvement of clinical outcomes in patients with acute myeloid leukemia.

Schlagwörter

Stichwörter der Autor:innen

AMLATGGVHDallogeneic stem cell transplantationbusulfan PK

Autor:innen und Institutionen

  • AOR Villa Sofia Cervello, Palermo, Italy.
  • CRQ Laboratory, Palermo, Italy.

ORCID-Profile: Luca Castagna

Zitieren

APA

Bono, R., Rotolo, C., Sapienza, G., Spoto, C., Costanza, C., Indelicato, S., Patti, C., Mulè, A., Calafiore, V., Arrigo, G., Santoro, A., Di Noto, L., & Castagna, L. (2026). In vivo T‐cell depletion and pharmacokinetic‐based busulfan conditioning regimen improve the outcomes in acute myeloid leukemia (AML) in complete remission undergoing to allogeneic stem cell transplantation. Cancer, 132(16). https://doi.org/10.1002/cncr.70545

Vancouver

Bono R, Rotolo C, Sapienza G, Spoto C, Costanza C, Indelicato S, et al. In vivo T‐cell depletion and pharmacokinetic‐based busulfan conditioning regimen improve the outcomes in acute myeloid leukemia (AML) in complete remission undergoing to allogeneic stem cell transplantation. Cancer. 2026;132(16). doi:10.1002/cncr.70545

BibTeX
@article{Bono2026,
  author = {Bono, Roberto and Rotolo, Cristina and Sapienza, Giuseppe and Spoto, Corinne and Costanza, Carmelo and Indelicato, Sergio and Patti, Caterina and Mulè, Antonino and Calafiore, Valeria and Arrigo, Giulia and Santoro, Alessandra and Di Noto, Laura and Castagna, Luca},
  title = {In vivo T‐cell depletion and pharmacokinetic‐based busulfan conditioning regimen improve the outcomes in acute myeloid leukemia (AML) in complete remission undergoing to allogeneic stem cell transplantation},
  journal = {Cancer},
  year = {2026},
  volume = {132},
  number = {16},
  doi = {10.1002/cncr.70545}
}
Kostenlos starten →